{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:54:14Z","timestamp":1788173654625,"version":"build-2803163510"},"reference-count":24,"publisher":"BMJ","issue":"14","funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["910210"],"award-info":[{"award-number":["910210"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2024,2,14]]},"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>We aimed to investigate the effectiveness of fixed-dose combination therapy (polypill) for primary and secondary prevention of major cardiovascular diseases in a typical rural setting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The PolyPars Study is a two-arm pragmatic cluster-randomised trial nested within the PARS cohort study, including all residents aged over 50 years in the entire district in southern Iran. The 91 villages underwent random allocation into two arms: the control arm, encompassing 45 clusters, was subjected to non-pharmacological intervention (educational training on healthy lifestyle), whereas the intervention arm, comprising 46 clusters, received the non-pharmacological interventions in conjunction with a once-daily polypill tablet. This tablet comprised two antihypertensive agents, a statin and aspirin. The primary outcome was the first occurrence of major cardiovascular events defined as a composite of hospitalisation for acute coronary syndrome (non-fatal myocardial infarction and unstable angina), fatal myocardial infarction, non-fatal and fatal stroke, sudden death and heart failure. The Cox regression model, with shared frailty, was used to account for clustering effect.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During December 2015\u2013December 2016, a total of 4415 participants aged 50\u201375 years were recruited (2200 participants in the intervention arm and 2215 participants in the control arm). The overall median of follow-up duration was 4.6 years (interquartile interval 4.4\u20134.9). The achieved adherence rate to polypill in intervention arm was 86%. In the control group, 176 (8.0%) of 2215 participants developed primary outcome, compared with 88 (4.0%) of 2200 participants in the polypill group. We found substantial reduction in risk of primary outcome both in relative and absolute scales (HR 0.50, 95% CI 0.38 to 0.65; absolute risk reduction 4.0%, 95%\u2009CI 2.5% to 5.3%). No difference in serious adverse events was observed between the two groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The fixed-dose combination therapy using polypill can safely halve the risk of major cardiovascular diseases at the population level.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03459560\">NCT03459560<\/jats:ext-link>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/heartjnl-2023-323614","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T17:20:33Z","timestamp":1710436833000},"page":"940-946","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness of polypill for primary and secondary prevention of cardiovascular disease: a pragmatic cluster-randomised controlled trial (PolyPars)"],"prefix":"10.1136","volume":"110","clinical-trial-number":[{"clinical-trial-number":"nct03459560","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03459560","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1043-3814","authenticated-orcid":false,"given":"Fatemeh","family":"Malekzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Gandomkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Poustchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Etemadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Roshandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4133-4870","authenticated-orcid":false,"given":"Armin","family":"Attar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firoozeh","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh","family":"Sadeghi Boogar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Mohammadkarimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Fattahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Mohagheghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Malekzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3669-5129","authenticated-orcid":false,"given":"Sadaf G","family":"Sepanlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"2024062503300662000_110.14.940.1","unstructured":"Institute for Health Metrics and Evaluation . GBD compare: viz hub, . 2019 Available: https:\/\/vizhub.healthdata.org\/gbd-compare\/ [Accessed 30 Jun 2023]."},{"key":"2024062503300662000_110.14.940.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"2024062503300662000_110.14.940.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.308903"},{"key":"2024062503300662000_110.14.940.4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMoa2208275","article-title":"Polypill strategy in secondary cardiovascular prevention","volume":"387","author":"Castellano","year":"2022","journal-title":"N Engl J Med"},{"key":"2024062503300662000_110.14.940.5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht407"},{"key":"2024062503300662000_110.14.940.6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(17)30553-6","article-title":"Uses of Polypills for cardiovascular disease and evidence to date","volume":"389","author":"Huffman","year":"2017","journal-title":"Lancet"},{"key":"2024062503300662000_110.14.940.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31791-X"},{"key":"2024062503300662000_110.14.940.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600176"},{"key":"2024062503300662000_110.14.940.9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa2028220","article-title":"Polypill with or without aspirin in persons without cardiovascular disease","volume":"384","author":"Yusuf","year":"2021","journal-title":"N Engl J Med"},{"key":"2024062503300662000_110.14.940.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600177"},{"key":"2024062503300662000_110.14.940.11","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(21)01827-4","article-title":"Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis","volume":"398","author":"Joseph","year":"2021","journal-title":"Lancet"},{"key":"2024062503300662000_110.14.940.12","doi-asserted-by":"crossref","first-page":"548","DOI":"10.34172\/aim.2020.58","article-title":"Effectiveness of Polypill for prevention of cardiovascular disease (Polypars): protocol of a randomized controlled trial","volume":"23","author":"Malekzadeh","year":"2020","journal-title":"Arch Iran Med"},{"key":"2024062503300662000_110.14.940.13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00038-016-0848-2","article-title":"Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results","volume":"62","author":"Gandomkar","year":"2017","journal-title":"Int J Public Health"},{"key":"2024062503300662000_110.14.940.14","first-page":"2313","article-title":"Hypertension surveillance in rural regions of Iran","volume":"48","author":"Panahi","year":"2019","journal-title":"Iran J Public Health"},{"key":"2024062503300662000_110.14.940.15","doi-asserted-by":"crossref","first-page":"e1346","DOI":"10.1016\/S2214-109X(19)30339-0","article-title":"Cost-effectiveness of a fixed-dose combination pill for secondary prevention of cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a Modelling study","volume":"7","author":"Lin","year":"2019","journal-title":"Lancet Glob Health"},{"key":"2024062503300662000_110.14.940.16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/ehjqcco\/qcz001","article-title":"The cost implication of primary prevention in the HOPE 3 trial","volume":"5","author":"Lamy","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2024062503300662000_110.14.940.17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ahj.2018.07.012","article-title":"The International Polycap Study-3 (TIPS-3): design, baseline characteristics and challenges in conduct","volume":"206","author":"Joseph","year":"2018","journal-title":"Am Heart J"},{"key":"2024062503300662000_110.14.940.18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.277064"},{"key":"2024062503300662000_110.14.940.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001862","article-title":"The Polypill: from promise to pragmatism","volume":"12","author":"Huffman","year":"2015","journal-title":"PLoS Med"},{"key":"2024062503300662000_110.14.940.20","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(17)30558-5","article-title":"Putting Polypills into practice: challenges and lessons learned","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"2024062503300662000_110.14.940.21","article-title":"Fixed-dose combination therapy for the prevention of Atherosclerotic cardiovascular diseases","volume":"3","author":"Bahiru","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2024062503300662000_110.14.940.22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(19)31949-X","article-title":"A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a cluster-randomised controlled trial","volume":"394","author":"Schwalm","year":"2019","journal-title":"Lancet"},{"key":"2024062503300662000_110.14.940.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30667-6"},{"key":"2024062503300662000_110.14.940.24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.amjcard.2023.06.001","article-title":"Meta-analysis on the clinical outcomes with Polypills for cardiovascular disease prevention","volume":"201","author":"Sedhom","year":"2023","journal-title":"Am J Cardiol"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2023-323614","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T10:31:48Z","timestamp":1719311508000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2023-323614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":24,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,6,25]]},"published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1136\/heartjnl-2023-323614"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2023-323614","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]}}}